• Policy
• Yoon Seok-yeol expands R&D for telemedicine & bio
• by Lee, Jeong-Hwan Mar 14, 2022 05:51am

• Policy
• P3T for Sarepta’s DMD treatment approved in Korea
• by Lee, Hye-Kyung Mar 14, 2022 05:51am

• Company
• Pharma·Biopharmas make or break COVID-19 CMO deals
• by Ji Yong Jun Mar 14, 2022 05:51am

• Policy
• Securing Paxlovid's inventory for 120,000 people
• by Lee, Jeong-Hwan Mar 14, 2022 05:50am

• Policy
• Yoon Seok Yeol's generation
• by Lee, Jeong-Hwan Mar 13, 2022 08:03pm

• Company
• Roche,set to establish a Korean precision medical ecosystem
• by jung, sae-im Mar 13, 2022 08:01pm

• Company
• Dong-A ST submitted an appeal against patent dispute
• by Kim, Jin-Gu Mar 13, 2022 07:59pm

• Company
• Sales of oral contraceptives rebound…4th gen Yaz sales up 2
• by Ji Yong Jun Mar 11, 2022 06:04am

• Company
• Global lead Humira’s sales drop... biosimilars occupy 16%
• by Chon, Seung-Hyun Mar 11, 2022 06:04am

• Company
• MSD’s 15-valent vaccine ‘Vaxneuvance’ comes to Korea
• by Eo, Yun-Ho Mar 10, 2022 05:54am